Hyperpituitarism
MONDO:0006793Disease of the glandular, anterior portion of the pituitary (pituitary gland, anterior) resulting in hypersecretion of adenohypophyseal hormones such as growth hormone; prolactin; thyrotropin; luteinizing hormone; follicle stimulating hormone ; and adrenocorticotropic hormone. Hyperpituitarism usually is caused by a functional adenoma.
59 clinical trials for this condition and its sub-types, 0 tagged with Hyperpituitarism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hyperpituitarism
-
Acromegaly 29 trials
-
ACTH-dependent Cushing syndrome 23 trials · 26 incl. sub-types
2 sub-types
- Cushing disease due to pituitary adenoma 23 trials
- Ectopic Cushing syndrome 1 trial
-
Hyperprolactinemia 9 trials
2 sub-types
- Acquired hyperprolactinemia 1 trial Sub-types →
- Familial hyperprolactinemia 0 trials
-
Pituitary gigantism 4 trials
Most studied deeper sub-types
-
New Long-Acting shot takes aim at Acromegaly's hormone overload
Disease control CompletedAcromegaly is a rare condition where the pituitary gland makes too much growth hormone, causing bones and tissues to enlarge. Researchers are testing a long-acting octreotide injection called SYHX2008 in 78 adults with active acromegaly. Participants receive either the new inject…
Phase 2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a Once-Monthly shot tame Acromegaly's hormone overdrive?
Disease control CompletedThis trial is testing whether a new, once-monthly injection of octreotide (CAM2029) can help people with acromegaly, a condition where the body makes too much growth hormone. Participants will receive either the study drug or a placebo for six months. The main goal is to see if t…
Phase 3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New monthly injection aims to tame acromegaly safely
Disease control CompletedThis study tested a monthly injection called CAM2029 (octreotide) in 135 adults with acromegaly, a condition where the body makes too much growth hormone. The goal was to see if the drug is safe and keeps hormone levels under control over 12 months. Participants had already been …
Phase 3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New hope for kids with gigantism: daily shot may tame growth hormone
Disease control CompletedThis study tested a drug called pegvisomant in children aged 2 to 18 with gigantism, a condition where the body makes too much growth hormone. The goal was to see if the drug could safely lower hormone levels and slow down abnormal growth. Participants received daily injections a…
Phase 3 • Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug shows promise for cortisol disorder
Disease control CompletedThis study tested an experimental drug called SPI-62 in 26 adults with Cushing's syndrome caused by a non-adrenal tumor. The goal was to see if SPI-62 could lower cortisol levels safely. Participants received either SPI-62 or a placebo for 24 weeks, with an option to continue lon…
Phase 2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a ketogenic diet tame acromegaly hormones?
Disease control CompletedThis study tested whether a three-week ketogenic diet could improve hormone and metabolic measures in 26 adults with active acromegaly, compared to a Mediterranean diet. Participants followed each diet for three weeks, with a two-week break in between. The main goal was to see ch…
Sponsor: University of Palermo • Aim: Disease control
Last updated Jun 26, 2026 14:16 UTC
-
Can a simple sugar test spot acromegaly better?
Diagnosis CompletedThis study looked at whether a standard glucose tolerance test (drinking a sugary solution) can reliably diagnose acromegaly, a condition caused by too much growth hormone. Researchers tested 109 people, some with acromegaly and some without, giving them two glucose tests and one…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
New PET/MRI scan could spot elusive brain tumors in Cushing's patients
Diagnosis CompletedThis study tested whether a special scan called [11C]-Methionine PET/MRI can better locate tiny pituitary tumors that cause Cushing's disease. Standard MRI often misses these tumors, leading to risky exploratory surgery. The study involved 33 adults with confirmed Cushing's disea…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New octreotide pill faces off against current capsule in healthy volunteer study
Knowledge-focused CompletedThis early-stage trial in 18 healthy adults compares a new octreotide tablet (T25) with an existing capsule (MYCAPSSA) to see how much drug gets into the blood. It also checks whether a high-fat meal changes absorption of the tablet. Participants take single doses under fasting o…
Phase 1 • Sponsor: Triastek (Shanghai) Limited • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a Growth-Hormone blocker stay safe in everyday use? a korean study investigates
Knowledge-focused CompletedThis observational study tracks patients in Korea who have been prescribed Somavert (pegvisomant) for acromegaly, a condition caused by too much growth hormone. Researchers will monitor side effects and whether patients show clinical improvement during routine treatment. The goal…
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New software could improve acromegaly care
Knowledge-focused CompletedThis study tested a new software tool called ACRODAT that helps doctors track disease activity in people with acromegaly. The tool looks at five key factors like hormone levels, symptoms, and quality of life. Researchers compared patients whose doctors used ACRODAT to those recei…
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Antipsychotic side effects in kids: new study probes hormone disruption
Knowledge-focused CompletedThis study looked at 90 children and teens (ages 7-18) taking antipsychotic medication to see how it affects their hormones, growth, and metabolism. Researchers measured prolactin levels and checked for links to sex hormones, metabolic health, and puberty development. The goal wa…
Sponsor: Ulla Schierup Nielsen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New study tracks hidden heart and bone risks in Cushing's disease
Knowledge-focused CompletedThis study followed 80 people with newly diagnosed Cushing's disease for three years to see how the disease affects the heart, bones, metabolism, and quality of life. Researchers used blood tests, heart scans, bone density tests, and questionnaires to track complications before a…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Can a simple test right after surgery predict acromegaly cure?
Knowledge-focused CompletedThis study followed 20 adults with acromegaly for one year after pituitary surgery. Researchers measured growth hormone and related substances at several time points to see if early test results could predict whether the disease goes into remission. The goal is to find better way…
Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Scleroderma mystery: could a simple hormone be involved?
Knowledge-focused CompletedThis study looked at whether people with systemic sclerosis (scleroderma) have higher levels of the hormone prolactin in their blood. Researchers measured prolactin in 71 patients and compared them to healthy volunteers. The goal was to understand if prolactin plays a role in the…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Virtual reality test reveals hidden memory damage in cured Cushing's patients
Knowledge-focused CompletedThis study looked at whether people who have been cured of Cushing's disease for at least a year still have memory problems. Researchers used a special virtual reality test to check memory, along with standard tests. The goal was to better understand these lasting effects and imp…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC